Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Multiple polymorphic loci determine basal hepatic and splenic iron status in mice.

Grant GR, Robinson SW, Edwards RE, Clothier B, Davies R, Judah DJ, Broman KW, Smith AG.

Hepatology. 2006 Jul;44(1):174-85.

PMID:
16799992
2.

Light pulse-induced heme and iron-associated transcripts in mouse brain: a microarray analysis.

Ben-Shlomo R, Akhtar RA, Collins BH, Judah DJ, Davies R, Kyriacou CP.

Chronobiol Int. 2005;22(3):455-71.

PMID:
16076647
3.

Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.

Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, Judah DJ, Dinsdale D, Edwards RE, Greaves P, Gant TW, Smith AG.

Am J Pathol. 2005 Apr;166(4):1041-53.

4.

Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after griseofulvin.

Gant TW, Baus PR, Clothier B, Riley J, Davies R, Judah DJ, Edwards RE, George E, Greaves P, Smith AG.

EHP Toxicogenomics. 2003 Jan;111(1T):37-43.

PMID:
12735108
5.

Differences in ethoxyquin nephrotoxicity between male and female F344 rats.

Neal GE, Judah DJ, Hard GG, Ito N.

Food Chem Toxicol. 2003 Feb;41(2):193-200.

PMID:
12480297
6.

Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat.

Donald S, Verschoyle RD, Edwards R, Judah DJ, Davies R, Riley J, Dinsdale D, Lopez Lazaro L, Smith AG, Gant TW, Greaves P, Gescher AJ.

Cancer Res. 2002 Aug 1;62(15):4256-62.

7.

Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance.

Turton NJ, Judah DJ, Riley J, Davies R, Lipson D, Styles JA, Smith AG, Gant TW.

Oncogene. 2001 Mar 15;20(11):1300-6.

8.

Differences detected in vivo between samples of aflatoxin-contaminated peanut meal, following decontamination by two ammonia-based processes.

Neal GE, Judah DJ, Carthew P, Verma A, Latour I, Weir L, Coker RD, Nagler MJ, Hoogenboom LA.

Food Addit Contam. 2001 Feb;18(2):137-49.

PMID:
11288911
10.

Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.

Stanley LA, Mandel HG, Riley J, Sinha S, Higginson FM, Judah DJ, Neal GE.

Cancer Lett. 1999 Apr 1;137(2):173-81.

PMID:
10374839
11.

Determinants of specificity for aflatoxin B1-8,9-epoxide in alpha-class glutathione S-transferases.

McDonagh PD, Judah DJ, Hayes JD, Lian LY, Neal GE, Wolf CR, Roberts GC.

Biochem J. 1999 Apr 1;339 ( Pt 1):95-101.

12.

Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers.

Manson MM, Hudson EA, Ball HW, Barrett MC, Clark HL, Judah DJ, Verschoyle RD, Neal GE.

Carcinogenesis. 1998 Oct;19(10):1829-36.

PMID:
9806166
13.

Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems.

Neal GE, Eaton DL, Judah DJ, Verma A.

Toxicol Appl Pharmacol. 1998 Jul;151(1):152-8.

PMID:
9705898
14.

Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.

Manson MM, Ball HW, Barrett MC, Clark HL, Judah DJ, Williamson G, Neal GE.

Carcinogenesis. 1997 Sep;18(9):1729-38.

PMID:
9328168
16.

In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1.

Riley J, Mandel HG, Sinha S, Judah DJ, Neal GE.

Carcinogenesis. 1997 May;18(5):905-10.

PMID:
9163674
17.

Regulation of carbonyl-reducing enzymes in rat liver by chemoprotectors.

Ellis EM, Judah DJ, Neal GE, O'Connor T, Hayes JD.

Cancer Res. 1996 Jun 15;56(12):2758-66.

18.

Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.

Hayes JD, McLeod R, Ellis EM, Pulford DJ, Ireland LS, McLellan LI, Judah DJ, Manson MM, Neal GE.

IARC Sci Publ. 1996;(139):175-87. Review.

PMID:
8923030
20.

Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.

McLellan LI, Judah DJ, Neal GE, Hayes JD.

Biochem J. 1994 May 15;300 ( Pt 1):117-24.

21.

The primary and secondary metabolism of aflatoxin B1 by rat hepatocytes cultured on matrigel.

Judah DJ, Davies R, Hayes JD, McLellan LI, Neal GE.

Toxicol Appl Pharmacol. 1994 Mar;125(1):27-33.

PMID:
8128492
22.

In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.

Kirby GM, Wolf CR, Neal GE, Judah DJ, Henderson CJ, Srivatanakul P, Wild CP.

Carcinogenesis. 1993 Dec;14(12):2613-20.

PMID:
8269634
23.
25.

A comparison of the effects of aflatoxin B1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks.

Seawright AA, Snowden RT, Olubuyide IO, Riley J, Judah DJ, Neal GE.

Hepatology. 1993 Jul;18(1):188-97.

PMID:
8325610
26.
27.

Effect of dietary protein level on aflatoxin B1 actions in the liver of weanling rats.

Mandel HG, Judah DJ, Neal GE.

Carcinogenesis. 1992 Oct;13(10):1853-7.

PMID:
1423844
30.

Investigation of the assay of AFB1-albumin adducts using proteolysis products in ELISA.

Olubuyide IO, Makarananda K, Judah DJ, Neal GE.

Int J Cancer. 1991 May 30;48(3):468-72.

PMID:
1904051
31.
32.

Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1.

Hayes JD, Judah DJ, McLellan LI, Neal GE.

Pharmacol Ther. 1991;50(3):443-72. Review.

PMID:
1754606
33.

The in vivo site of formation of a carcinogen-serum albumin adduct.

Okoye ZS, Riley J, Judah DJ, Neal GE.

Biochem Pharmacol. 1990 Dec 1;40(11):2560-2. No abstract available.

PMID:
2125223
34.

Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.

Forrester LM, Neal GE, Judah DJ, Glancey MJ, Wolf CR.

Proc Natl Acad Sci U S A. 1990 Nov;87(21):8306-10.

36.

Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.

Mandel HG, Manson MM, Judah DJ, Simpson JL, Green JA, Forrester LM, Wolf CR, Neal GE.

Cancer Res. 1987 Oct 1;47(19):5218-23.

37.
38.

The mercapturic acid pathway metabolites of a glutathione conjugate of aflatoxin B1.

Moss EJ, Neal GE, Judah DJ.

Chem Biol Interact. 1985 Oct;55(1-2):139-55.

PMID:
3933841
39.

Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1.

Moss EJ, Judah DJ, Przybylski M, Neal GE.

Biochem J. 1983 Jan 15;210(1):227-33.

41.

The microsomal activation of aflatoxin B1 and 2-(N-ethylcarbamoyloxymethyl)furan in vitro using a novel diffusion apparatus.

Neal GE, Mattocks AR, Judah DJ.

Biochim Biophys Acta. 1979 Jun 1;585(1):134-42. No abstract available.

PMID:
36175
42.

Effect of hypophysectomy and aflatoxin B1 on rat liver.

Neal GE, Judah DJ.

Cancer Res. 1978 Oct;38(10):3460-7. No abstract available.

43.

Development of resistance to cytotoxicity during aflatoxin carcinogenesis.

Judah DJ, Legg RF, Neal GE.

Nature. 1977 Jan 27;265(5592):343-5. No abstract available.

PMID:
834282
44.

The effects of prolonged feeding with aflatoxin B1 on adult rat liver.

Godoy HM, Judah DJ, Arora HL, Neal GE, Jones G.

Cancer Res. 1976 Jul;36(7 PT 1):2399-407.

PMID:
1277145
45.

Some effects of acute and chronic dosing with aflatoxin B1 on rat liver nuclei.

Neal GE, Judah DJ, Butler WH.

Cancer Res. 1976 May;36(5):1771-8.

Supplemental Content

Loading ...
Support Center